Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treprostinil - SciPharm Sarl

Next Previous
Search
Drug Profile

Treprostinil - SciPharm Sarl

Alternative Names: Treprostinil sodium - SciPharm SàRL; Trepulmix

Latest Information Update: 16 Nov 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SciPharm Sarl
  • Class Acetic acids; Antifibrotics; Antihypertensives; Cyclopentanes; Naphthalenes; Prostaglandins; Skin disorder therapies; Small molecules; Vasodilators
  • Mechanism of Action Epoprostenol receptor agonists; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pulmonary hypertension
  • New Molecular Entity No

Highest Development Phases

  • Registered Pulmonary hypertension

Most Recent Events

  • 09 Sep 2023 Efficacy and adverse event data from phase-III CTREPH trial in Pulmonary hypertension presented at the 33rd Annual Congress of the European Respiratory Society (ERS-2023)
  • 30 Apr 2021 SciPharm Sarl completes a phase-III CTREPH trial in Austria, Czech republic, Germany, Poland and Slovakia (NCT01416636) (EudraCT2008-006441-10)
  • 17 Mar 2021 Phase III CTREPH trial is still ongoing in Pulmonary hypertension in Poland, Germany, Czech Republic, Austria (SC) (NCT01416636; EudraCT2008-006441-10)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top